(Q34623504)

3 August 2017

Melatonin decreases delirium in elderly patients: a randomized, placebo-controlled trial (English)

1 reference

3 August 2017

0 references

0 references

1 reference

1 reference

Tareef Al-Aama

1

1 reference

3 August 2017

Christopher Brymer

2

1 reference

3 August 2017

Iris Gutmanis

3

1 reference

3 August 2017

Sarah M Woolmore-Goodwin

4

1 reference

3 August 2017

Jacquelin Esbaugh

5

1 reference

3 August 2017

Monidipa Dasgupta

6

1 reference

3 August 2017

language of work or name

English

0 references

publication date

15 September 2010

1 reference

International Journal of Geriatric Psychiatry

3 August 2017

1 reference

3 August 2017

26

1 reference

3 August 2017

7

1 reference

3 August 2017

687-694

1 reference

Melatonin: possible implications for the postoperative and critically ill patient

3 August 2017

1 reference

Drug treatment of delirium: past, present and future

21 January 2018

1 reference

The Memorial Delirium Assessment Scale.

21 January 2018

1 reference

The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis

21 January 2018

1 reference

Diagnosis and treatment of dementia: introduction. Introducing a series based on the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia

21 January 2018

1 reference

Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance

21 January 2018

1 reference

Treating insomnia: Current and investigational pharmacological approaches

21 January 2018

1 reference

Delirium risk factors in elderly hospitalized patients

21 January 2018

1 reference

Sleep and delirium in ICU patients: a review of mechanisms and manifestations

21 January 2018

1 reference

Melatonin for treatment and prevention of postoperative delirium

21 January 2018

1 reference

Delirium in older persons

21 January 2018

1 reference

A multicomponent intervention to prevent delirium in hospitalized older patients.

21 January 2018

1 reference

Clarifying confusion: the confusion assessment method. A new method for detection of delirium

21 January 2018

1 reference

Melatonin for the treatment of dementia

21 January 2018

1 reference

Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: a randomized placebo-controlled study.

21 January 2018

1 reference

Insomnia in the elderly: cause, approach, and treatment

21 January 2018

1 reference

Persistent delirium predicts greater mortality

21 January 2018

1 reference

Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy

21 January 2018

1 reference

Postoperative delirium: the tryptophan dyregulation model

21 January 2018

1 reference

A multifactorial intervention program reduces the duration of delirium, length of hospitalization, and mortality in delirious patients

21 January 2018

1 reference

Reducing delirium after hip fracture: a randomized trial

21 January 2018

1 reference

Outcomes of older people admitted to postacute facilities with delirium.

21 January 2018

1 reference

Serum biomarkers for delirium

21 January 2018

1 reference

Melatonin in elderly patients with insomnia. A systematic review

21 January 2018

1 reference

Plasma tryptophan and tyrosine levels are independent risk factors for delirium in critically ill patients.

21 January 2018

1 reference

Low tryptophan levels are associated with postoperative delirium in the elderly

21 January 2018

1 reference

Interventions for preventing delirium in hospitalised patients

21 January 2018

1 reference

Melatonin as a hypnotic: con.

21 January 2018

1 reference

Melatonin as a hypnotic: pro.

21 January 2018

1 reference

Melatonin Treatment for Age-Related Insomnia

21 January 2018

1 reference

Melatonin in older people with age-related sleep maintenance problems: a comparison with age matched normal sleepers.

21 January 2018

1 reference

7 January 2021

Randomisation in clinical trials

1 reference

7 January 2021

1 reference

7 January 2021

A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.

1 reference

7 January 2021

The Canadian Study of Health and Aging: risk factors for Alzheimer's disease in Canada

1 reference

7 January 2021

Identifiers

DOI

10.1002/GPS.2582

1 reference

3 August 2017

1 reference